Oruka Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $841.0K | $37.9M | $37.4M |
| FY2024 | $13.8M | $1.0K | $61.6M |
| FY2025 | $16.7M | $488.6M | $46.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $841.0K | $37.9M | $37.4M |
| FY2024 | $13.8M | $1.0K | $61.6M |
| FY2025 | $16.7M | $488.6M | $46.9M |